Concepedia

Mark T. Marino

MT

Statistics

Publications

14

Citations

598

H-Index

13

Active since

1990

Affiliations

MannKind Corporation (United States)(Current)

Walter Reed Army Institute of Research

AGCO (United Kingdom)

University of California, San Francisco

Mark T. Marino is an author at MannKind Corporation (United States) specializing in pharmacy, pharmacology, and pharmacokinetics.

ORCID

Publications per year

1990–2012

14

Publications

14

Grapefruit Juice Reduces the Oral Bioavailability of Fexofenadine But Not Desloratadine

Christopher Banfield, Samir K. Gupta, Mark T. Marino et al. · Clinical Pharmacokinetics · 2002 · 97 citations

, , +5

Pharmacokinetic and safety profile of desloratadine and fexofenadine when coadministered with azithromycin: a randomized, placebo-controlled, parallel-group study

Samir K. Gupta, Christopher Banfield, Bhavna Kantesaria et al. · Clinical Therapeutics · 2001 · 87 citations

, , +10

Pharmacokinetics and linear exposure of AFRESA™ compared with the subcutaneous injection of regular human insulin

Klaus Rave, Elizabeth Potocka, Anders Boss et al. · Diabetes Obesity and Metabolism · 2009 · 78 citations

, , +17

Insulin Lung Deposition and Clearance Following Technosphere® Insulin Inhalation Powder Administration

James Cassidy, Nikhil Amin, Mark T. Marino et al. · Pharmaceutical Research · 2011 · 71 citations

, , +12

Population Pharmacokinetics and Pharmacodynamics of Pyridostigmine Bromide for Prophylaxis against Nerve Agents in Humans

Mark T. Marino, Brian G. Schuster, Ralf P. Brueckner et al. · The Journal of Clinical Pharmacology · 1998 · 51 citations

, , +17

1–5 of 14